UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): April 22, 2003
EDWARDS LIFESCIENCES CORPORATION
(Exact name of registrant as specified in its charter)
| Delaware (State or other jurisdiction of incorporation) |
1-15525 (Commission file number) |
36-4316614 (IRS Employer Identification No.) |
||
One Edwards Way, Irvine, California (Address of principal executive offices) |
92614 (Zip Code) |
|||
(949) 250-2500
Registrant's telephone number, including area code
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
Item 9. Regulation FD Disclosure.
The following information is furnished pursuant to Item 9—Regulation FD Disclosure and Item 12—Disclosure of Results of Operations and Financial Condition.
On April 22, 2003, Edwards Lifesciences Corporation, a Delaware corporation, issued a press release setting forth Edwards Lifesciences' first quarter 2003 financial results. A copy of the press release is attached as Exhibit 99.
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: April 22, 2003 | ||||
EDWARDS LIFESCIENCES CORPORATION |
||||
By: |
/s/ BRUCE P. GARREN Bruce P. Garren Corporate Vice President, General Counsel and Secretary |
|||
3
| Exhibit Number |
Description |
|
|---|---|---|
| 99 | Press release, dated April 22, 2003, reporting Edwards Lifesciences' financial results for the first quarter 2003 |
4